Page last updated: 2024-11-11

venalot

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Cross-References

ID SourceID
PubMed CID6335951
MeSH IDM0061721

Synonyms (4)

Synonym
2h-1-benzopyran-2-one mixt. with 2-(3,4-bis(2- hydroxyethoxy)phenyl)-3-((6-o-(6-deoxy-alpha-l- mannopyranosyl)-beta-d-glucopyranosyl)oxy)-5- hydroxy-7-(2-hydroxyethoxy)-4h-1-benzopyran-4-one
venalot
2h-1-benzopyran-2-one, mixt. with 2-(3,4-bis(2-hydroxyethoxy)phenyl)-3-((6-o-(6-deoxy-alpha-l-mannopyranosyl)-beta-d-glucopyranosyl)oxy)-5-hydroxy-7-(2-hydroxyethoxy)-4h-1-benzopyran-4-onehydrogen sulfate sodium salt
39291-13-9

Research Excerpts

Toxicity

ExcerptReferenceRelevance
" However, no adverse effect on body weight gain, food or water consumption, ophthalmoscopic or electrocardiographic examinations were noted in any other animals during this study."( Toxicity of venalot (a mixture of coumarin and troxerutin) in the baboon.
Heywood, R; Majeed, SK; Pulsford, AH; Street, AE, 1983
)
0.64

Dosage Studied

ExcerptRelevanceReference
" Increased levels of liver function (serum leucine amino-peptidase (LAP), and serum ornithine carbamyl transferase (OCT) were noted during the dosing period, together with slightly increased liver weights terminally for animals receiving 1000 mg/kg/day; however, as no morphological or ultrastructural changes were noted, these findings were considered to be attributable to hypertrophy."( Toxicity of venalot (a mixture of coumarin and troxerutin) in the baboon.
Heywood, R; Majeed, SK; Pulsford, AH; Street, AE, 1983
)
0.64
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (25)

TimeframeStudies, This Drug (%)All Drugs %
pre-199021 (84.00)18.7374
1990's0 (0.00)18.2507
2000's4 (16.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 57.81

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be very strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index57.81 (24.57)
Research Supply Index3.64 (2.92)
Research Growth Index4.14 (4.65)
Search Engine Demand Index138.49 (26.88)
Search Engine Supply Index3.00 (0.95)

This Compound (57.81)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials11 (42.31%)5.53%
Reviews0 (0.00%)6.00%
Case Studies2 (7.69%)4.05%
Observational0 (0.00%)0.25%
Other13 (50.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]